|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
|
Alaunos Therapeutics, Inc. (Name of Issuer) |
Common stock (Title of Class of Securities) |
98973P309 (CUSIP Number) |
Samuel E. Whitley 24285 Katy Freeway, Suite 300 Katy, TX, 77494 2812060434 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
10/30/2025 (Date of Event Which Requires Filing of This Statement) |

SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Chris Butterworth | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,700.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Richard Jones | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
16,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.7 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Edward Jones | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
11,750.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Gareth Downing | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
19,522.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.9 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Richard Kotey | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
12,530.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Chris Cole | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
15,856.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.7 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Arif Chaudrey | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
6,423.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Emma Babb | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,366.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Colin Craig | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
John Nicholls | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
16,743.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.8 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Carl Ware | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
1,721.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.1 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Andrew Turner | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
13,035.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Matthew Robbins | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,036.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Phillip James Stead | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
11,012.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Stephen Hennessy | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
7,108.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.3 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Greg Arnold | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
10,735.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Michelle Douglas | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
8,494.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| CUSIP No. | 98973P309 |
| 1 |
Name of reporting person
Price Adrian | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
189,061.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
| 13 | Percent of class represented by amount in Row (11)
8.6 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common stock | |
| (b) | Name of Issuer:
Alaunos Therapeutics, Inc. | |
| (c) | Address of Issuer's Principal Executive Offices:
501 E LAS OLAS BLVD, 501 E LAS OLAS BLVD, FORT LAUDERDALE,
FLORIDA
, 33301. | |
Item 1 Comment:
This Amendment No. 1 to Schedule 13D (this Amendment) relates to the Schedule 13D filed on October 30, 2025 (the Initial 13D) by the Reporting Persons, relating to the shares of common stock, $0.001 par value, of Alaunos Pharmaceuticals, Inc. This Amendment is being filed solely to attach powers of attorney as exhibits to this Amendment. All other information in the Initial 13D filed by the Reporting Persons with the SEC remains the same. | ||
| Item 2. | Identity and Background | |
| (a) | The below persons are collectively referred to herein as the Reporting Persons. Each of the Reporting Persons files this Schedule 13D jointly. The Reporting Persons are filing this Schedule 13D jointly, as they may be considered a Group under Section 13(d)(3) of the Act. However, neither the fact of this filing nor anything contained herein shall be deemed to be an admission by the Reporting Persons that such a group exists.
Chris Butterworth
Richard Jones
Edward Jones
Gareth Downing
Richard Kotey
Chris Cole
Arif Chaudrey
Emma Babb
Colin Craig
John Nicholls
Carl Ware
Andrew Turner
Matthew Robbins
Phillip James Stead
Stephen Hennessy
Greg Arnold
Michelle Douglas | |
| (b) | Chris Butterworth: 12A Grahamshill Street, Airdrie, ML6 7EN, United Kingdom
Richard Jones: 28 Jedburgh Street, Blantyre, Glasgow, South Lanarkshire, G72 0SU, United Kingdom
Edward Jones: 21 Langdale Avenue, Formby, Liverpool, L37 2LB, United Kingdom
Gareth Downing: 14 Osier Way, Banstead, SM7 1LL, United Kingdom
Richard Kotey: 13 Mendez Way, London, SW15 5GA, United Kingdom
Chris Cole: 18 Herons Way, Hayling Islang, Hants, PO11 9FL, United Kingdom
Arif Chaudrey: 25 Bays Crescent, Spencers Wood, Reading, RG7 1DF, United Kingdom
Emma Babb: 71 Stanborrough Avenue, Borhamwood, Harts, WD6 5LX, United Kingdom
Colin Craig: 43 Inverary Drive, Belfast, BT4 1RD, United Kingdom
John Nicholls: 41 Lea Castle Drice, Lea Castle, Kiddermister, Worcs, DY10 3FB, United Kingdom
Carl Ware: 20 Roveley Court, Stony Stratford, Milton Keynes, MK11 1NU, United Kingdom
Andrew Turner: 26 Sun Vale Avenue, Todmorden, West Yorkshire, OL14 6TP, United Kingdom
Matthew Robbins: 42 Tattersall Road, Yate, Bristol, BS37 7GW, United Kingdom
Phillip James Stead: 113 Dartmouth Avenue, Wallsal, West Midlands, WS3 1SP, United Kingdom
Stephen Hennessy: 57 Regent House, Station Road, Strood, Kent, ME2 4WQ, United Kingdom
Greg Arnold: 1 Hickling Close, Long Eaton, Nottingham, NG10 3TE, United Kingdom
Michelle Douglas: 13 Mendez Way, London, SW15 5GA, United Kingdom | |
| (c) |
Chris Butterworth: self-employed electrician;12A Grahamshill Street, Airdrie, ML6 7EN, United Kingdom
Richard Jones: manager at Balfour Beatty; Huntly Road, Glasgow, G52 4DZ, United Kingdom
Edward Jones: self-employed software developer; 21 Langdale Avenue, Formby, Liverpool, L37 2LB, United Kingdom
Gareth Downing: ops manager at M Group; Gunnells Eood Rd, Stevenage, United Kingdom
Richard Kotey: tutor at United Colleges Group; 26 Paddington Green, W2 1NB, United Kingdom
Chris Cole: self-employed carpenter; 18 Herons Way, Hayling Islang, Hants, PO11 9FL, United Kingdom
Arif Chaudrey: petroleum engineer at KBR Consulting; KT22 7NL, Letterhead, United Kingdom
Emma Babb: housewife; 71 Stanborrough Avenue, Borhamwood, Harts, WD6 5LX, United Kingdom
Colin Craig: support worker/subcontractor at various companies; 43 Inverary Drive, Belfast, BT4 1RD, United Kingdom
John Nicholls: field service engineer at Clearmark Solutions; Olympic House, Nottingham, NG15 0DP, United Kingdom
Carl Ware: self-employed IT consultant; 20 Roveley Court, Stony Stratford, Milton Keynes, MK11 1NU, United Kingdom
Andrew Turner: ops manager at Urbasers; 3 Sidings Court, Doncaster DN4 5NU, United Kingdom
Matthew Robbins: student at Bristol University; Beacon House Bristol, BS8 1QU, United Kingdom
Phillip James Stead: events manager at Walsal FC; Beacon House Bristol, BS8 1QU, United Kingdom
Stephen Hennessy: engineer at Go Fix; Beechcroft Farm ind estate, TN15 7HX, United Kingdom
Greg Arnold: project supervisor at CITY; Caldonia House Glasgow, United Kingdom
Michelle Douglas: manager at NHS; PO Box 130, Morden, SM4 9EF, United Kingdom | |
| (d) | Chris Butterworth: No
Richard Jones: No
Edward Jones: No
Gareth Downing: No
Richard Kotey: No
Chris Cole: No
Arif Chaudrey: No
Emma Babb: No
Colin Craig: No
John Nicholls: No
Carl Ware: No
Andrew Turner: No
Matthew Robbins: No
Phillip James Stead: No
Stephen Hennessy: No
Greg Arnold: No
Michelle Douglas: No | |
| (e) |
Chris Butterworth: No
Richard Jones: No
Edward Jones: No
Gareth Downing: No
Richard Kotey: No
Chris Cole: No
Arif Chaudrey: No
Emma Babb: No
Colin Craig: No
John Nicholls: No
Carl Ware: No
Andrew Turner: No
Matthew Robbins: No
Phillip James Stead: No
Stephen Hennessy: No
Greg Arnold: No
Michelle Douglas: No | |
| (f) | Chris Butterworth: United Kingdom
Richard Jones: United Kingdom
Edward Jones: United Kingdom
Gareth Downing: United Kingdom
Richard Kotey: United Kingdom
Chris Cole: United Kingdom
Arif Chaudrey: United Kingdom
Emma Babb: United Kingdom
Colin Craig: United Kingdom
John Nicholls: United Kingdom
Carl Ware: United Kingdom
Andrew Turner: United Kingdom
Matthew Robbins: United Kingdom
Phillip James Stead: United Kingdom
Stephen Hennessy: United Kingdom
Greg Arnold: United Kingdom
Michelle Douglas: United Kingdom | |
| Item 3. | Source and Amount of Funds or Other Consideration | |
Chris Butterworth: personal funds
Richard Jones: personal funds
Edward Jones: personal funds
Gareth Downing: personal funds
Richard Kotey: personal funds
Chris Cole: personal funds
Arif Chaudrey: personal funds
Emma Babb: personal funds
Colin Craig: personal funds
John Nicholls: personal funds
Carl Ware: personal funds
Andrew Turner: personal funds
Matthew Robbins: personal funds
Phillip James Stead: personal funds
Stephen Hennessy: personal funds
Greg Arnold: personal funds
Michelle Douglas: personal funds | ||
| Item 4. | Purpose of Transaction | |
The Reporting Persons intend to approach the Board of Directors of Alaunos in order to discuss ways to create shareholder value. The Reporting Persons may suggest nominees to Alaunos Board of Directors in order to help Alaunos search for profitable strategic acquisitions. The Reporting Persons have not yet formulated a specific proposal for the Board of Directors of Alaunos, nor do they have identified a specific strategic acquisition to propose to the Board of Directors of Alaunos. The Reporting Persons have appointed Adrian Price as their representative to approach the Board of Directors of Alaunos.
The Reporting Persons may purchase and sell common stock of Alaunos in their sole discretion and at such times as they deem convenient, subject to applicable law.
Other than as set forth above, the Reporting Persons do not intend to take any of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D at this time; however, they reserve the right to do so. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | The information contained in Rows 7, 8, 9, 10, 11, and 13 of each Reporting Person's cover page to this Schedule 13D (including the footnotes thereto), and in Items 2 and 3 of this amendment, are incorporated by reference into this Item 5. Adrian Price disclaims beneficial ownership of the securities discussed herein. | |
| (b) | The information contained in Rows 7, 8, 9, 10, 11, and 13 of each Reporting Person's cover page to this Schedule 13D (including the footnotes thereto), and in Items 2 and 3 of this amendment, are incorporated by reference into this Item 5. Adrian Price disclaims beneficial ownership of the securities discussed herein. | |
| (c) | The Reporting Persons have not conducted any in Alaunos securities in the past 60 days. | |
| (d) | N/A | |
| (e) | N/A | |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
The Reporting Persons have entered into a Joint Filing Agreement, which is set forth hereto as Exhibit 99.1.
The Reporting Persons have granted Adrian Price a power of attorney to sign and file this Schedule 13D (and any amendments) and the Joint Filing Agreement with the Securities and Exchange Commission. These powers of attorney are set forth as Exhibits 99.2 through 99.18.
Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of Alaunos. | ||
| Item 7. | Material to be Filed as Exhibits. | |
Exhibit 1 Joint Filing Agreement
Exhibit 2 Power of Attorney: Chris Butterworth
Exhibit 3 Power of Attorney: Richard Jones
Exhibit 4 Power of Attorney: Edward Jones
Exhibit 5 Power of Attorney: Gareth Downing
Exhibit 7 Power of Attorney: Richard Kotey
Exhibit 8 Power of Attorney: Chris Cole
Exhibit 9 Power of Attorney: Arif Chaudrey
Exhibit 10 Power of Attorney: Emma Babb
Exhibit 11 Power of Attorney: Colin Craig
Exhibit 12 Power of Attorney: John Nicholls
Exhibit 13 Power of Attorney: Carl Ware
Exhibit 14 Power of Attorney: Andrew Turner
Exhibit 15 Power of Attorney: Matthew Robbins
Exhibit 16 Power of Attorney: Phillip James Stead
Exhibit 17 Power of Attorney: Stephen Hennessy
Exhibit 18 Power of Attorney: Greg Arnold
Exhibit 19 Power of Attorney: Michelle Douglas | ||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|